WINTON GROUP Ltd Cuts Stake in Envista Holdings Co. (NYSE:NVST)

WINTON GROUP Ltd cut its position in Envista Holdings Co. (NYSE:NVSTFree Report) by 1.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 413,945 shares of the company’s stock after selling 7,214 shares during the quarter. WINTON GROUP Ltd’s holdings in Envista were worth $7,985,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Iron Triangle Partners LP bought a new position in shares of Envista during the third quarter valued at $43,262,000. Point72 Asset Management L.P. bought a new position in Envista during the 3rd quarter valued at about $37,559,000. Polar Asset Management Partners Inc. lifted its stake in Envista by 375.6% during the 3rd quarter. Polar Asset Management Partners Inc. now owns 1,497,250 shares of the company’s stock valued at $29,586,000 after acquiring an additional 1,182,450 shares during the period. Pzena Investment Management LLC purchased a new stake in shares of Envista during the 4th quarter valued at about $16,979,000. Finally, Franklin Resources Inc. grew its stake in shares of Envista by 26.5% in the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock worth $78,480,000 after acquiring an additional 830,861 shares during the period.

Envista Stock Up 0.5 %

NVST opened at $17.55 on Thursday. The stock has a market cap of $3.02 billion, a price-to-earnings ratio of -2.70, a price-to-earnings-growth ratio of 1.27 and a beta of 1.33. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. The firm’s fifty day moving average is $19.67 and its 200 day moving average is $19.59. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $23.00.

Envista (NYSE:NVSTGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, sell-side analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on NVST shares. Wells Fargo & Company set a $19.00 target price on shares of Envista in a report on Saturday, March 8th. UBS Group dropped their price target on Envista from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Monday, March 10th. Morgan Stanley reduced their price objective on Envista from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Thursday, March 6th. Mizuho initiated coverage on Envista in a research report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 target price on the stock. Finally, Piper Sandler increased their price objective on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Monday, February 3rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $20.18.

Get Our Latest Analysis on NVST

About Envista

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Recommended Stories

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.